Premium
IL‐1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double‐Bind Placebo‐Controlled Clinical Trial
Author(s) -
Mauro Giuffrè,
Daniele Macor,
Flora Masutti,
C. Abazia,
Fabio Tinè,
R. Patti,
Matteo Rossano Buonocore,
Anna Colombo,
Alessia Visintin,
Michele Campigotto,
Saveria Croce
Publication year - 2018
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.30353
Subject(s) - pentoxifylline , medicine , placebo , antagonist , alcoholic hepatitis , multicenter trial , randomized controlled trial , gastroenterology , pharmacology , receptor antagonist , clinical trial , receptor , multicenter study , alcoholic liver disease , pathology , cirrhosis , alternative medicine